Literature DB >> 2953336

Peptidyl fluoromethyl ketones as thiol protease inhibitors.

E Shaw, H Angliker, P Rauber, B Walker, P Wikstrom.   

Abstract

The fluoromethyl ketone derivatives of peptides are now available through several synthetic approaches and can be examined with respect to their properties as protease inhibitors. It had been expected that the fluoro atom might be too inert for nucleophilic displacement and that irreversible inactivation might not be achievable by this type of derivative in contrast to chloromethyl ketones. However, with serine and cysteinyl proteases, alkylation of the enzyme does take place although the rates are not similar to those of the chloromethyl ketones. Of the two classes, thiol proteases are more readily inactivated and the fluoromethyl ketones are almost as effective as the chloromethyl ketones. Our observations confirm and extend those of Rasnick (Anal. Biochem. 149, 461-465 (1985)). The structure of the peptidyl portion of the reagent controls specificity of inhibition in the typical manner of affinity-labels for proteases. However, fluoromethyl ketones are considerably less reactive to nucleophiles such as the thiol group of glutathione, than chloromethyl ketones and, therefore, this new class of inhibitors may provoke fewer side reactions when used in biological studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2953336

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  4 in total

1.  The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents.

Authors:  H Angliker; P Wikstrom; H Kirschke; E Shaw
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Cysteine Cathepsins Inhibition Affects Their Expression and Human Renal Cancer Cell Phenotype.

Authors:  Magdalena Rudzińska; Alessandro Parodi; Valentina D Maslova; Yuri M Efremov; Neonila V Gorokhovets; Vladimir A Makarov; Vasily A Popkov; Andrey V Golovin; Evgeni Y Zernii; Andrey A Zamyatnin
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

3.  Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases.

Authors:  A Pant; R Kumar; N A Wani; S Verma; R Sharma; V Pande; A K Saxena; R Dixit; R Rai; K C Pandey
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

Review 4.  Proteolysis and antigen presentation by MHC class II molecules.

Authors:  Paula Wolf Bryant; Ana-Maria Lennon-Duménil; Edda Fiebiger; Cécile Lagaudrière-Gesbert; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2002       Impact factor: 3.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.